An appeals court has ruled that Google will have to deal with an investigation into its business practices by Mississippi Attorney General Jim Hood. The court also noted the search company can still challenge the investigation at a later time.
It’s a reversal of a big win by Google last year when a federal judge halted the Mississippi investigation, which sought information about how Google deals with links related to counterfeit goods, illegal drug sales, copyright violations, and other matters. Google sued to stop the investigation while litigation was underway, saying that Hood’s goal was to “punish” Google while he pursued his goal of a “pre-filtered Internet”—a power denied him by both Congress and the Constitution, Google lawyers argued.
Hood’s investigation had been egged on by lobbyists from the Motion Picture Association of America, and in some cases demand letters that came from Hood’s office were actually written by MPAA lawyers.
Today, the US Court of Appeals for the 5th Circuit overturned Google’s win on procedural grounds. In a 23-page opinion, a three-judge panel said that the district court judge had been too quick to grant relief to Google.
“This injunction covers a fuzzily defined range of enforcement actions that do not appear imminent,” the appeals judges held. “We cannot on the present record predict what conduct Hood might one day try to prosecute under Mississippi law.”
Hood’s subpoenas were a “pre-litigation investigative tool” seeking information about a wide array of topics, including copyright infringement, illegal prescription drug sales, human trafficking, false IDs, and credit card theft.
Full content: The Hill
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas